Department of Internal Medicine, Emergency and Surgery (DIMES), Alma Mater Studiorum, University of Bologna, S.Orsola-Malpighi Hospital, Italy.
Pancreatology. 2013 Nov-Dec;13(6):589-93. doi: 10.1016/j.pan.2013.09.001. Epub 2013 Sep 19.
The prognostic role of lymph nodes metastasis in pancreatic neuroendocrine tumours is unclear.
Retrospective study of 53 patients who underwent a curative standard resection for pancreatic neuroendocrine tumours. The endpoint was to define the role of the lymph nodes ratio in recurrence after curative surgery. The following data were considered as possible factors for predicting the risk of recurrence: gender, age, presence of symptoms, hormonal status, site of tumours, type of resection, size of the tumours, radical resection, pathological T, N and M stage, the Ki67 index, the number of lymph nodes harvested, the number of metastatic lymph nodes and the lymph node ratio. Recurrence rate and time of recurrence were evaluated.
Twelve (26.4%) patients developed a recurrence with a median time of 42.8 (1-305) months. At multivariate analysis, the only factors related to recurrence were: size of lesions (HR 1.1, C.I. 95% 1.0-1.1, P = 0.011), Ki67 ≥ 5% (HR 3.6, C.I. 95% 1.3-10, P = 0.014) and LNR > 0.07 (HR 5.2, C.I. 95% 1.1-25, P = 0.045).
Our study confirmed that the lymph nodes ratio played an important role in the recurrence rate and suggested that a low number of metastatic lymph nodes reduced the disease free survival.
淋巴结转移对胰腺神经内分泌肿瘤的预后作用尚不清楚。
回顾性分析 53 例接受根治性标准切除术的胰腺神经内分泌肿瘤患者。终点是确定淋巴结比值在根治性手术后复发中的作用。考虑了以下数据作为预测复发风险的可能因素:性别、年龄、症状存在、激素状态、肿瘤部位、手术类型、肿瘤大小、根治性切除、病理 T、N 和 M 分期、Ki67 指数、采集的淋巴结数量、转移淋巴结数量和淋巴结比。评估了复发率和复发时间。
12 例(26.4%)患者出现复发,中位时间为 42.8(1-305)个月。多因素分析显示,与复发相关的唯一因素为:病变大小(HR 1.1,95%CI 1.0-1.1,P=0.011)、Ki67≥5%(HR 3.6,95%CI 1.3-10,P=0.014)和 LNR>0.07(HR 5.2,95%CI 1.1-25,P=0.045)。
本研究证实了淋巴结比值在复发率中起着重要作用,并提示转移淋巴结数量较少会降低无病生存率。